Zealthy review

What it is

Zealthy is the brand of FitRX, LLC, a New York company based at 30 Irving Place in Manhattan. Besides weight loss it offers primary care, mental health, birth control, hair loss, skin care, sleep and erectile dysfunction treatment. Medical care is provided by affiliated medical groups named in its terms, including Bruno Health, P.A. and Outlast Health; Zealthy provides the management and administrative services. Its clinicians are described as U.S.-licensed, board-certified physicians and nurse practitioners. Compounded medication is prepared by a state-licensed sterile compounding pharmacy that the site doesn't name. A LegitScript seal image appears in its footer, but it doesn't load, so check LegitScript's own website before relying on it. The weight program isn't available to people using government insurance such as Medicare or Medicaid, and the site doesn't list the states it serves.

How it works

You answer an online intake about your health, weight history and preferences, and a Zealthy provider reviews it, typically within one to two business days. The program is fully online. After that, you get unlimited secure messaging with your provider, monthly video or phone visits for check-ins, a dedicated coach, and messaging with a care coordinator in the Zealthy portal or app. If a brand-name drug is prescribed, the coordination team gathers the paperwork and submits a prior authorization to your insurer; decisions usually come back in two to 14 business days, and Zealthy will resubmit up to three times after a denial. Many members start on compounded medication while that plays out. To keep an approved prior authorization active, you need to stay a member. Compounded medication ships from a partner pharmacy after approval, usually arriving five to nine business days after the prescription is sent. Memberships can't be paused, but you can delay a shipment from the portal.

Pricing transparency

There are two ways to pay. The membership is $135 a month (the first month is discounted), billed on the same date each month. It covers clinician care, coaching and insurance coordination but not medication. With insurance, Zealthy says some members pay as little as a $25 copay for a covered brand-name drug. Without it, compounded semaglutide is sold from $151 a month and tirzepatide from $216 a month, with shipping included, when you buy a three-month supply at a 20% discount; the one-month price isn't published. The bundle is the simpler route: the Semaglutide Bundle is $217 for the first month and $297 a month after, and the Tirzepatide Bundle is $349 and then $449, with care and medication included. Zealthy notes that extra fees may apply if your provider prescribes doses above the standard titration schedule. If you're found ineligible for compounded medication, you get a refund. Otherwise, all medication sales are final once the pharmacy fills the order, and consultation and membership fees are non-refundable. You can cancel any time in the portal, under Manage membership, before the next renewal; access continues to the end of the paid month. HSA and FSA cards are accepted, although the membership fee itself usually isn't a covered expense.

Branded vs compounded

Brand-name Wegovy, Zepbound, Ozempic and Mounjaro, generally through insurance, and compounded semaglutide and tirzepatide by weekly injection. Wegovy and Zepbound are FDA-approved for weight management; Ozempic and Mounjaro are approved for type 2 diabetes and prescribed off-label for weight. Zealthy's own disclosure notes that compounded GLP-1s are not FDA-approved. That matters for the evidence: the 15% to 20% average weight loss figures on Zealthy's pages come from trials of the branded drugs, not compounded versions. In September 2025 the FDA sent Zealthy a warning letter about its website's claims for compounded semaglutide, including wording that presented it as the active ingredient in Wegovy and Ozempic, which the agency said implied the compounded product was the same as an approved drug. Zealthy's weight pages describe its compounded semaglutide in similar terms. The same parent company, FitRX, LLC, received further letters in February 2026 for its FitRx brand and in June 2026 for its AM RX brand. The September 2025 letter is disclosed and linked on this page.

Pros and watch-outs

The evidence behind what Zealthy prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Zepbound vs Wegovy: what the trials actually show

  Zepbound (tirzepatide) leads on weight loss in the one head-to-head trial; Wegovy (semaglutide) has the cardiovascular-outcomes approval. An honest comparison.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

How Zealthy compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Found

  Compounded GLP-1 with the drug included, and insurance for the visits

  See Found →
• SnagRx

  Naming the pharmacies that actually fill the prescription

  See SnagRx →
• Ro

  A polished, well-resourced end-to-end program

  See Ro →

More GLP-1 telehealth reviews: New Wave Health · Eviora MD · Hers · Midi Health · Remedy Meds · OrderlyMeds